Empyrean Neuroscience
Pre-clinicalDevelops novel therapeutics targeting neurological disorders using computational drug discovery approaches.
Founded
2021
Focus
Small Molecules
About
Develops novel therapeutics targeting neurological disorders using computational drug discovery approaches.
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile